Obesity

One anastomosis gastric bypass as a one-stage bariatric surgical procedure in patients with BMI ≥ 50 kg/m2

One anastomosis gastric bypass as a one-stage bariatric surgical procedure in patients with BMI ≥ 50 kg/m2

This prospective study was conducted on patients with severe obesity and BMI ≥ 50 kg/m2 aged 18 years and above who had undergone primary OAGB from January 2016 to February 2019 with at least 2 years follow-ups at the Rasool-e Akram Hospital, an accredited Center of Excellence of the European Branch of the International Federation …

One anastomosis gastric bypass as a one-stage bariatric surgical procedure in patients with BMI ≥ 50 kg/m2 Read More »

Trumping Obesity With Tirzepatide – Docwire News

Trumping Obesity With Tirzepatide – Docwire News

Obesity is a highly prevalent disease in the United States (US), with prevalence rates over 40% (1). Obesity-related complications most commonly include heart disease, stroke, and type-2 diabetes, leading to higher costs of medical care for obese individuals, contributing to over 170 billion dollars in healthcare costs in the US (2). To combat the rising …

Trumping Obesity With Tirzepatide – Docwire News Read More »

Disparities in obesity rates seen among US adolescents

Disparities in obesity rates seen among US adolescents

Socioeconomic disparities in obesity prevalence grew from 1999 to 2018 among US adolescents, according to a research letter published online June 21 in JAMA Pediatrics† Ryunosuke Goto, MD, from the University of Tokyo Hospital, and colleagues used data from the 1999 to 2018 US National Health and Nutrition Examination Surveys to examine obesity trends among …

Disparities in obesity rates seen among US adolescents Read More »

Rhythm Pharmaceuticals Announces that European Commission Authorized Variation for IMCIVREE® (setmelanotide) to Allow for Dosing in Patients with POMC or LEPR deficiency with Renal Impairment

Rhythm Pharmaceuticals Announces that European Commission Authorized Variation for IMCIVREE® (setmelanotide) to Allow for Dosing in Patients with POMC or LEPR deficiency with Renal Impairment

BOSTON† June 22, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, announced today that the European Commission (EC) this week authorized a variation for IMCIVREE (setmelanotide) that allows for dosing in patients with POMC or LEPR …

Rhythm Pharmaceuticals Announces that European Commission Authorized Variation for IMCIVREE® (setmelanotide) to Allow for Dosing in Patients with POMC or LEPR deficiency with Renal Impairment Read More »

Healthy lunch ideas: Obese woman who ‘couldn’t wear shoes’ because of her size reveals simple food swaps that saw her shed half her bodyweight

Healthy lunch ideas: Obese woman who ‘couldn’t wear shoes’ because of her size reveals simple food swaps that saw her shed half her bodyweight

A 19st 2lb size 24 grandmother who loves baking and whose 30-year weight struggles peaked after she lost her husband to bone marrow cancer has shed nearly 9st to reach her 10st 6lb size 12 goal just before turning 60. Weight first became an issue for retired nurse Christine Burnell, 59, following the birth of …

Healthy lunch ideas: Obese woman who ‘couldn’t wear shoes’ because of her size reveals simple food swaps that saw her shed half her bodyweight Read More »

Rhythm Pharmaceuticals Launches IMCIVREE® (setmelanotide) in Germany for the Treatment of Obesity and Control of Hunger Associated with POMC or LEPR Deficiency

Rhythm Pharmaceuticals Launches IMCIVREE® (setmelanotide) in Germany for the Treatment of Obesity and Control of Hunger Associated with POMC or LEPR Deficiency

Rhythm Pharmaceuticals, Inc. BOSTON, June 22, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, today announced IMCIVREE (setmelanotide) is now available to patients in Germany. IMCIVREE, a melanocortin-4 receptor (MC4R) agonist, last year received marketing authorization …

Rhythm Pharmaceuticals Launches IMCIVREE® (setmelanotide) in Germany for the Treatment of Obesity and Control of Hunger Associated with POMC or LEPR Deficiency Read More »

Highlights from the Endocrine Society’s annual meeting

Highlights from the Endocrine Society’s annual meeting

ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on † ” data-action=subscribe> Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back …

Highlights from the Endocrine Society’s annual meeting Read More »

Global Anti-obesity Medicine Market 2022 Driving Factors and Major Key Players – Alizyme, Amylin Pharmaceuticals, Arena Pharmaceuticals, Boehringer Ingelheim, Eisai

Global Anti-obesity Medicine Market 2022 Driving Factors and Major Key Players – Alizyme, Amylin Pharmaceuticals, Arena Pharmaceuticals, Boehringer Ingelheim, Eisai

MarketQuest.biz just issued a study on the Global Anti-obesity Medicine Market from 2022 to 2028† It focuses on the main factors, market strategies, and the successful development of key players. Policymakers and corporate leaders may use the findings to make more cost-effective strategic decisions. The report offers an unbiased and in-depth examination of current trends, …

Global Anti-obesity Medicine Market 2022 Driving Factors and Major Key Players – Alizyme, Amylin Pharmaceuticals, Arena Pharmaceuticals, Boehringer Ingelheim, Eisai Read More »

Pet Obesity Management Market Size, Scope and Forecast

Pet Obesity Management Market Size, Scope and Forecast

New Jersey, United States – The Pet Obesity Management Market research report examines the market in precise detail during the anticipated period. The research is divided into sections, each of which includes a market trend and change analysis. Drivers, limits, possibilities, and hurdles, as well as the impact of numerous aspects on the sector, are …

Pet Obesity Management Market Size, Scope and Forecast Read More »